---
id: 57
registrationType: 境外生产药品
genericName: 利普卡替尼
productName: 利普卡替尼片
productNameEn: Ripretinib Tablets
brandName: 艾瑞妮
brandNameEn: Qinlock
category: 化学药品
formulation: 片剂
specification: 50mg
registrationNumber: 国药准字HJ20190378
mahName: Deciphera Pharmaceuticals, LLC
mahAddress: 200 Smith Street, Waltham, MA 02451, USA
manufacturerName: Deciphera Pharmaceuticals, LLC
manufacturerAddress: 643 South Pierce Avenue, Louisville, KY 40217, USA
manufacturerCountry: 美国
packagingName: 齐鲁制药有限公司
packagingAddress: 山东省济南市高新区开拓路7号
approvalDate: 2019-12-10
isOriginal: true
originator: Deciphera Pharmaceuticals, LLC
originatorSource:
  - type: FDA橙皮书
    url: https://www.accessdata.fda.gov/scripts/cder/ob/patent_info.cfm?Product_No=001&Appl_No=213973
  - type: 企业年报
    url: https://investors.deciphera.com/financial-information/annual-reports
originalException: "原研企业授权济南工厂分装"
---

## 适应症

1. 既往治疗失败的胃肠道间质瘤
2. 四线及以上治疗的胃肠道间质瘤
3. 耐药性胃肠道间质瘤
4. 转移性胃肠道间质瘤

## 注意事项

1. 监测心电图QT间期
2. 监测肝功能
3. 注意皮肤不良反应
4. 避免与强CYP3A抑制剂合用

## 不良反应

- 脱发
- 恶心
- 疲劳
- 腹痛
- 肌痛 